This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from March 14-17, 2022
Attend In-Person or 100% Digitally!San Diego Convention Center, San Diego, California

Christina Tsai, PhD
Senior Scientist at IGM Biosciences


Christina Tsai is a senior scientist in the Cell Line Development Group in IGM Biosciences. Her work in IGM is focused on CHO cell line development and particularly in the proteomic and genomic identification of cell lines for the production of intact IgM molecules. She has 10+ years of experience in process development in various kinds of cell lines, including CHO, HEK, Pichia, etc. Prior to IGM, she works on cell line development and IgG molecule characterization in Hengenix Biotech and Samsung Biologics. In addition, she founded a microbiome company, EpiBiome, which was acquired by Locus Biosciences.

Agenda Sessions

  • Cell line characterization for IgM molecules in cell line development process